Prognostic model for long-term survival of locally advanced non-small-cell lung cancer patients after neoadjuvant radiochemotherapy and resection integrating clinical and histopathologic factors

被引:0
|
作者
Christoph Pöttgen
Martin Stuschke
Britta Graupner
Dirk Theegarten
Thomas Gauler
Verena Jendrossek
Lutz Freitag
Jehad Abu Jawad
Eleni Gkika
Jeremias Wohlschlaeger
Stefan Welter
Matthias Hoiczyk
Martin Schuler
Georgios Stamatis
Wilfried Eberhardt
机构
[1] University of Duisburg-Essen,Department of Radiotherapy, West German Cancer Center
[2] University of Duisburg-Essen,Institute of Pathology and Neuropathology, West German Cancer Center
[3] University of Duisburg-Essen,Department of Medical Oncology, West German Cancer Center
[4] University of Duisburg-Essen,Institute of Cell Biology (Cancer Research)
[5] University of Duisburg-Essen,Division of Interventional Pneumology, Ruhrlandklinik,West German Lung Center
[6] University of Duisburg-Essen,Division of Thoracic Surgery and Thoracic Endoscopy, Ruhrlandklinik, West German Lung Center
[7] University of Duisburg-Essen,Division of Thoracic Oncology, Ruhrlandklinik, West German Lung Center
[8] German Cancer Consortium (DKTK),undefined
来源
BMC Cancer | / 15卷
关键词
Prognostic model; Long-term survival; NSCLC; Histopathological response;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Prognostic model for long-term survival of locally advanced non-small-cell lung cancer patients after neoadjuvant radiochemotherapy and resection integrating clinical and histopathologic factors
    Poettgen, Christoph
    Stuschke, Martin
    Graupner, Britta
    Theegarten, Dirk
    Gauler, Thomas
    Jendrossek, Verena
    Freitag, Lutz
    Abu Jawad, Jehad
    Gkika, Eleni
    Wohlschlaeger, Jeremias
    Welter, Stefan
    Hoiczyk, Matthias
    Schuler, Martin
    Stamatis, Georgios
    Eberhardt, Wilfried
    [J]. BMC CANCER, 2015, 15
  • [2] Prognostic Model for the Long Term-Survival of Patients with locally advanced non-small cell Lung Cancer (NSCLC) after neoadjuvant Radiochemotherapy (CT/RT) and Resection
    Poettgen, C.
    Graupner, B.
    Theegarten, D.
    Gauler, T.
    Kleinhans, J.
    Jendrossek, V
    Freitag, L.
    Abu Jawad, J.
    Gkika, E.
    Wohlschlaeger, J.
    Welter, S.
    Hoiczyk, M.
    Schuler, M.
    Stamatis, G.
    Eberhardt, W.
    Stuschke, M.
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2014, 190 : 17 - 17
  • [3] Neoadjuvant concurrent radiochemotherapy in locally advanced (IIIA-IIIB) non-small-cell lung cancer: long-term results according to downstaging
    Trodella, L
    Granone, P
    Valente, S
    Margaritora, S
    Macis, G
    Cesario, A
    D'Angelillo, RM
    Valentini, V
    Corbo, GM
    Porziella, V
    Ramella, S
    Tonini, G
    Galetta, D
    Ciresa, M
    Vincenzi, B
    Cellinil, N
    [J]. ANNALS OF ONCOLOGY, 2004, 15 (03) : 389 - 398
  • [4] Long-term survival after complete resection of non-small-cell lung cancer in patients with interstitial lung disease
    Sekihara, Keigo
    Aokage, Keiju
    Oki, Tomonari
    Omori, Tomokazu
    Katsumata, Shinya
    Ueda, Takuya
    Miyoshi, Tomohiro
    Goto, Masaki
    Nakasone, Shoko
    Ichikawa, Tomohiro
    Hishida, Tomoyuki
    Yoshida, Junji
    Hisakane, Kakeru
    Goto, Koichi
    Tsuboi, Andmasahiro
    [J]. INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2018, 26 (04) : 638 - 643
  • [5] Long-term results in patients with pathological complete response after induction radiochemotherapy followed by surgery for locally advanced non-small-cell lung cancer†
    Lococo, Filippo
    Cesario, Alfredo
    Margaritora, Stefano
    Dall'Armi, Valentina
    Mattei, Francesca
    Romano, Rosalia
    Porziella, Venanzio
    Granone, Pierluigi
    [J]. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2013, 43 (03) : E71 - E81
  • [6] Radiochemotherapy with Taxol for locally advanced non-small-cell lung cancer
    Willner, J
    Flentje, M
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 1999, 175 : 14 - 19
  • [7] Prognostic factors for long term survival in patients with advanced non-small cell lung cancer
    Moumtzi, Despoina
    Lampaki, Sofia
    Zarogoulidis, Paul
    Porpodis, Konstantinos
    Lagoudi, Kalliopi
    Hohenforst-Schmidt, Wolfgang
    Pataka, Athanasia
    Tsiouda, Theodora
    Zissimopoulos, Athanasios
    Lazaridis, George
    Karavasilis, Vasilis
    Timotheadou, Helen
    Barbetakis, Nikolaos
    Pavlidis, Pavlos
    Kontakiotis, Theodoros
    Zarogoulidis, Konstantinos
    [J]. ANNALS OF TRANSLATIONAL MEDICINE, 2016, 4 (09)
  • [8] Analysis of long-term survival in patients with locally advanced non-small cell lung cancer
    Wagner, W
    Striehn, E
    Klinke, F
    Bosse, U
    Rube, C
    [J]. ONCOLOGY REPORTS, 1998, 5 (06) : 1547 - 1550
  • [9] Long-term survivors of advanced non-small-cell lung cancer: characterisation and prognostic factors in a retrospective study
    Dujon, C.
    Azarian, R.
    Petitpretz, P.
    [J]. REVUE DES MALADIES RESPIRATOIRES, 2009, 26 (09) : 952 - 960
  • [10] LONG-TERM RESULTS OF NEOADJUVANT IFOSFAMIDE, CISPLATIN, AND ETOPOSIDE COMBINATION IN LOCALLY ADVANCED NON-SMALL-CELL LUNG-CANCER
    PUJOL, JL
    HAYOT, M
    ROUANET, P
    LECHEVALIER, T
    MICHEL, FB
    [J]. CHEST, 1994, 106 (05) : 1451 - 1455